文献速递心力衰竭与心肌病

全球心力衰竭患者再入院率的比较

Global Comparison of Readmission Rates for Patients With Heart Failure.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

该系统综述与荟萃分析汇总了2010年至2021年间发表的观察性报告,评估住院成年心衰患者的30天和1年全因再入院率及死亡率。各国间风险差异显著,且不能由GDP、卫生支出比例或基尼系数解释。

要点

  • 住院心衰患者30天再入院率13.2%,1年再入院率35.7%。
  • 30天死亡率为7.6%,1年死亡率为23.3%。
  • 各国再入院率差异大,未由经济或共病因素解释。

核心结论

  • 全球住院心衰患者再入院率和死亡率均较高,且再入院率的国家间差异不能由卫生支出、死亡风险或共病解释。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和CENTRAL数据库,纳入2010年1月至2021年3月发表的关于住院成年心衰患者再入院或死亡风险的观察性报告,采用随机效应模型合并比例,并用meta回归探索异质性来源。

主要发现

  • 各国间风险差异显著,但该差异不能由国家的国内生产总值、卫生保健支出占GDP比例和基尼系数解释。

临床怎么用

  • 临床应关注心衰患者出院后的早期再入院和死亡风险,30天和1年再入院率及死亡率可作为质量改进的参考基准。
  • 鉴于再入院率的国际差异不能由经济或共病因素解释,可探索并分享区域性的患者管理策略以改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure (HF) readmission rates are low in some jurisdictions. However, international comparisons are lacking and could serve as a foundation for identifying regional patient management strategies that could be shared to improve outcomes. OBJECTIVES: This study sought to summarize 30-day and 1-year all-cause readmission and mortality rates of hospitalized HF patients across countries and to explore potential differences in rates globally. METHODS: We performed a systematic review and meta-analysis using MEDLINE, Embase, and CENTRAL for observational reports on hospitalized adult HF patients at risk for readmission or mortality published between January 2010 and March 2021. We conducted a meta-analysis of proportions using a random-effects model, and sources of heterogeneity were evaluated with meta-regression. RESULTS: In total, 24 papers reporting on 30-day and 23 papers on 1-year readmission were included. Of the 1.5 million individuals at risk, 13.2% (95% CI: 10.5%-16.1%) were readmitted within 30 days and 35.7% (95% CI: 27.1%-44.9%) within 1 year. A total of 33 papers reported on 30-day and 45 papers on 1-year mortality. Of the 1.5 million individuals hospitalized for HF, 7.6% (95% CI: 6.1%-9.3%) died within 30 days and 23.3% (95% CI: 20.8%-25.9%) died within 1 year. Substantial variation in risk across countries was unexplained by countries' gross domestic product, proportion of gross domestic product spent on health care, and Gini coefficient. CONCLUSIONS: Globally, hospitalized HF patients exhibit high rates of readmission and mortality, and the variability in readmission rates was not explained by health care expenditure, risk of mortality, or comorbidities.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Foroutan, Rayner, Ross, et al. Global Comparison of Readmission Rates for Patients With Heart Failure. J Am Coll Cardiol. 2023. PMID: 37495280. doi:10.1016/j.jacc.2023.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。